Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma

被引：0
|
作者：
Tomohiko Kamimura
Toshihiro Miyamoto
Shuichiro Takashima
Noriko Yokota
Yong Chong
Yoshikiyo Ito
Koichi Akashi
机构：
[1] Harasanshin Hospital,Department of Hematology
[2] Kyushu University,Department of Medicine and Biosystemic Science, Graduate School of Medical Science
[3] Harasanshin Hospital,Department of Nursing
来源：
International Journal of Hematology | 2012年 / 96卷
关键词：
Multiple Myeloma; Bortezomib; Japanese Patient; Subcutaneous Administration; Injection Site Reaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：525 / 527
页数：2
相关论文
共 50 条
  • [1] Injection site reaction after subcutaneous administration of bortezomib in Japanese patients with multiple myeloma
    Kamimura, Tomohiko
    Miyamoto, Toshihiro
    Takashima, Shuichiro
    Yokota, Noriko
    Chong, Yong
    Ito, Yoshikiyo
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (04) : 525 - 527
  • [2] An Acceptable Incidence of Infusion Site Reactions after Subcutaneous Bortezomib Administration in the Upper Arm in Japanese Patients with Multiple Myeloma
    Ohgiya, Daisuke
    Tsuchiya, Takahide
    Suyama, Takahiro
    Watanabe, Shigeki
    Numata, Hiroki
    Tsuboi, Kosuke
    Sasao, Tamotsu
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 29 - 30
  • [3] Pharmacokinetics (PK) and Pharmacodynamics (PD) of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma: Effects of Subcutaneous Injection Site and Concentration, and Patient Characteristics
    Moreau, Philippe
    Karamanesht, Ievgenii I.
    Domnikova, Natalia
    Kyselyova, Maryna Y.
    Vilchevska, Kateryna
    Doronin, Vadim A.
    Schmidt, Alexander
    Hulin, Cyrille
    Leleu, Xavier
    Esseltine, Dixie-Lee
    Venkatakrishnan, Karthik
    Skee, Donna M.
    Feng, Huaibao
    Girgis, Suzette
    Cakana, Andrew Z.
    Deraedt, William M.
    Facon, Thierry
    BLOOD, 2011, 118 (21) : 811 - 812
  • [4] EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS INJECTION OF BORTEZOMIB IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA
    Fu, C.
    Liu, H.
    Wu, D.
    Xue, S.
    Li, W.
    Wu, Q.
    Gu, B.
    Jin, S.
    Zhu, X.
    Zhao, S.
    Xin, X.
    Ma, L.
    Sun, A.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S452 - S452
  • [5] Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma
    Moreau, Philippe
    Coiteux, Valerie
    Hulin, Cyrille
    Leleu, Xavier
    van de Velde, Helgi
    Acharya, Milin
    Harousseau, Jean-Luc
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1908 - 1911
  • [6] DOMESTIC SUBCUTANEOUS SELF-INJECTION OF BORTEZOMIB IN MULTIPLE MYELOMA
    Cerchione, C.
    Madonna, E.
    Fabbricini, R.
    Marano, L.
    Pugliese, N.
    Avilia, S.
    Cerciello, G.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2013, 98 : 597 - 598
  • [7] DOMESTIC SUBCUTANEOUS SELF-INJECTION OF BORTEZOMIB IN MULTIPLE MYELOMA
    Cerchione, C.
    Nappi, D.
    Migliaccio, I.
    Salvatore, D.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2016, 101 : 801 - 801
  • [8] Subcutaneous Bortezomib In Multiple Myeloma
    Hoy, Sheridan M.
    DRUGS, 2013, 73 (01) : 45 - 54
  • [9] Subcutaneous versus Intravenous Bortezomib Administration for Multiple Myeloma Patients:a Meta-analysis
    牟时代
    艾利莎
    秦铀
    胡豫
    Current Medical Science, 2018, 38 (01) : 43 - 50
  • [10] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF BORTEZOMIB IN PATIENTS WITH MULTIPLE MYELOMA: EXPERIENCE IN A SINGLE INSTITUTION
    Lopez San Roman, I.
    De Miguel, D.
    Golbano, N.
    Diaz Morfa, M.
    Morales, D.
    Arbeteta, J.
    Herrero, S.
    Subira, D.
    Pinedo, B.
    HAEMATOLOGICA, 2012, 97 : 603 - 603
12345